{
  "N/R/U": null,
  "Applicant": "Novartis Pharmaceuticals Corporation",
  "BLA Number": "125326",
  "Proprietary Name": "Kesimpta",
  "Proper Name": "ofatumumab",
  "BLA Type": "351(a)",
  "Strength": "20MG/0.4ML",
  "Dosage Form": "Injection ",
  "Route of Administration": "Subcutaneous",
  "Product Presentation": "Pre-Filled Syringe",
  "Marketing Status": "Disc",
  "Licensure": "Licensed",
  "Approval Date": "20-Aug-20",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": "70",
  "Submission Type": "Supplement",
  "License Number": "1244",
  "Product Number": "4",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": null
}